ENDOPLASMIC RETICULUM AMINO PEPTIDASE 1 (ERAP1) IN ANKYLOSING SPONDYLITIS
Romanian Journal of Rheumatology · 2015
DOI: 10.37897/rjr.2015.1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Rheumatology, 2015. Verfasst von Marius Cherciu und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Recently, endoplasmic reticulum aminopeptidase 1 (ERAP1) gene polymorphisms were associated with ankylosing spondylitis (AS) in genome-wide association studies (GWAS), associations which later were replicated across different populations, including the Romanian population. ERAP1 enzyme was proved to be involved in the final trimming, to the optimal length, of the antigenic peptides before loading them to human leucocyte antigen (HLA) class I molecules, different variants of ERAP1 being able to modify the types of peptides presented by HLA I molecules (including HLA-B27) to the CD8+ T cells. This article presents a detailed description of the functions, structure and the pathogenic potential of ERAP1 in AS.
Zitieren
APA
Cherciu, M., Bojinca, M., Cherciu, L. I., Bara, C., & Popa, O. M. (2015). ENDOPLASMIC RETICULUM AMINO PEPTIDASE 1 (ERAP1) IN ANKYLOSING SPONDYLITIS. Romanian Journal of Rheumatology. https://doi.org/10.37897/rjr.2015.1.4
Vancouver
Cherciu M, Bojinca M, Cherciu LI, Bara C, Popa OM. ENDOPLASMIC RETICULUM AMINO PEPTIDASE 1 (ERAP1) IN ANKYLOSING SPONDYLITIS. Romanian Journal of Rheumatology. 2015. doi:10.37897/rjr.2015.1.4
BibTeX
@article{Cherciu2015,
author = {Cherciu, Marius and Bojinca, Mihai and Cherciu, Laura Ioana and Bara, Constantin and Popa, Olivia Mihaela},
title = {ENDOPLASMIC RETICULUM AMINO PEPTIDASE 1 (ERAP1) IN ANKYLOSING SPONDYLITIS},
journal = {Romanian Journal of Rheumatology},
year = {2015},
doi = {10.37897/rjr.2015.1.4}
}
EUVIMED